Protective effects of Yangambin - A naturally occurring platelet-activating factor (PAF) receptor antagonist - On anaphylactic shock in rats

Phytomedicine

Volumn 3, Issue 3, 1996, Pages 249-256

  Ribeiro, R ^a   Carvalho, F A S ^a   Barbosa Filho, J M ^b   Cordeiro, R S B ^a   Tibirica E V ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

(+) yangambin; Anaphylactic; Arterial hypotension; Ocotea duckei Vattimo (Lauraceae); PAF receptor antagonist; systemic anaphylaxis; Shock

Indexed keywords

ANIMALIA; LAURACEAE; OCOTEA; OCOTEA DUCKEI;

EID: 0000358055     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(96)80062-6     Document Type: Article

References (50)

1. Austen, K. F.: The anaphylactic syndrome. In: Sampler M., ed. Immunological Diseases. Boston: Little & Brown, 885-899, 1978.
2. Bakathir, H. A., Giessler, J., Hirschelmann, R.: Rat heart anaphylaxis: influence of mediator antagonists. Gen Pharmacol. 22: 675-675, 1991.
3. Bernat, A., Herbert, J. M., Salel, V., Lespy, L., Maffrand, P.: Protective effects of SR 27417, a novel PAF antagonist, on PAF- or endotoxin-induced hypotension in the rat and the guinea pig. J. Lipid Mediators 51: 41-48, 1992.
4. Bessin, P., Bonnet, J., Apffel, D., Soulard, C., Desgroux, L., Pelas, I., Benveniste, J.: Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. Eur. J. Pharmacol. 86: 403-413, 1983.
5. Bochner, B. S., Lichtenstein, L. M.: Anaphylaxis. N. Engl. J. Med. 324: 1785-1790, 1991.
6. Booth, B. H.: Electrocardiographic changes during human anaphylaxis. JAMA 211: 627-631, 1970.
7. Braquet, P., Touqui, L., Shen, T. Y., Vargaftig, B. B.: Perspectives in platelet-activating factor research. Pharmacol. Rev. 39: 97-145, 1987.
8. Camussi, G., Alloatti, G., Monttucchio, G., Meda, M., Emmanuelli, G.: Effect of platelet-activating factor on guinea-pig papillary muscle. Experientia 40: 357-361, 1984.
9. Carceller, E., Merlos, M., Giral, M., Balsa, D., Almansa, C., Bartroli, J., Garcia-Rafanell, J., Forn, J.: [(3- Pyridylalkyl)piperidylidene]benzocyclohepatapyridine derivatives as dual antagonists of PAF and histamine. J. Med. Chem. 37: 2697-2703, 1994.
10. Casals-Stenzel, J.: Protective effect of WEB 2086, a novel antagonist of platelet-activating factor, in endotoxin shock. Eur. J. Pharmacol. 135: 117-122, 1987.
11. Casals-Stenzel, J., Muacevic, G., Weber, K. H.: Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J. Pharmacol. Exp. Ther. 241: 974-981, 1987.
12. Castro-Faria-Neto, H. C., Martins, M. A., Silva, P. M. R. Bozza, P. Cruz, H. N., De Queiroz-Paulo, M., Kaplan, M. A. C., Cordeiro, R. S. B.: Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activity. J. Lipid Mediators 7: 1-9, 1993.
13. Castro-Faria-Neto, H. C., Bozza, P. T., Thomas, G. Cruz, H. N., Silva, C. L. M., Violante, F., Thomas, G., Barbosa-Filho, J. M., Martins, M. A., Tibiriçá, E., Noel, F., Cordeiro, R. S. B.: Yangambin, a new naturally-occurring platelet- activating factor receptor antagonist: in vitro pharmacological studies. Planta Med 61: 101-105, 1995a.
14. Castro-Faria-Neto, H. C., Araújo, C. V., Moreira, S., Bozza, P. T., Thomas, G., Barbosa-Filho, J. M., Cordeiro, R. S. B., Tibiriçá, E.: Yangambin, a new naturally-occurring platelet-activating factor receptor antagonist: in vivo pharmacological studies. Planta Med 61: 106-112, 1995 b.
15. Chang, S. W., Feddersen, C. O., Henson, P. M., Voelkel, N. F.: Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin treated rats. J. Clin. Invest 81: 1498-1508, 1987.
16. Darius, H., Lefer, D. J., Smith, J. B., Lefer, A. M.: Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. Sciene 232: 58-60, 1986.
17. Dattwyler, R., Kaplan, A. P., Austen, K. F.: Human anaphylaxis. In: Kaplan, A. P. ed. Allergy. New York, Churchill Livingstone, 559-607, 1985.
18. De Queiroz-Paulo, M., Kaplan, M. A. C., Laprevote, O., Roblot, F., Hocquemiller, R., Cave, A.: Lignans and other non-alkaloidal constituents from Rollinea mucosa. Fitoterapia 62: 150-152, 1991.
19. Deitch, E. A.: Multiple organ failure: pathophysiology and potential future therapy. Ann. Surg. 216: 117-134, 1992.
20. Dirkes, K. Harris, B. H., Connolly, R. J., Schwaitzberg, S. D., Dinarello, C. A., Gelfand, J. A.: Platelet-activating factor antagonist improves survival in experimental staphylococcal septicemia. J. Pediatr. Surg. 29: 1055-1058, 1994.
21. Doeber, T. W., Wu, M. S., Robbins, J. C., Choy, B. M., Chang, M. N., Shen, T. Y.: Platelet-activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem. Biophys. Res. Commun. 127: 799-808, 1985.
22. Garcez-do-Carmo, L., Cordeiro, R., Lagente, V., Lefort, J., Randon, J., Vargaftig, B. B.: Failure of a combined anti-histamine and anti-leukotriene treatment to supress passive anaphylaxis in the guinea-pig. Int. J. Immunopharmac. 8: 985-995, 1986.
23. Herbert, J. M., Lespy, L., Maffrand, J. P.: Protective effect of SR 27417, a novel PAF-antagonist, on lethal anaphylactic and endotoxic-induced shocks in mice. Eur. J. Pharmacol. 205: 271-276, 1991.
24. Imanishi, N., Murakami-Uchida, M., Koike, H., Natsume, Y., Morooka, S.: Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrocloride. Arzneim. Forsch. 44: 317-322, 1994.
25. Inarrea, P., Gomez-Cambronero, J., Pascual del Carmen Ponte, M., Hernando, L., Sanchez-Crespo, M.: Synthesis of PAF-acether and blood volume changes in gramnegative sepsis. Immunopharmacol. 9: 45-52, 1985.
26. Kawamura, M., Kitayoshi, T., Terashita, Z. I., Fujiwara, S., Takatani, M., Nishikawa, K.: Effects of TCV-309, an novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogs. J. Lipid Mediat. Cell Singal. 9: 255-265, 1994.
27. Lefer, A. M., B.: Pathophysiological mechanisms of sudden death induced by platelet-activating factor. Br. J. Pharmacol. 83: 125-130, 1984.
28. Levi, R., Burke, J. A., Guo, Z. G., Hattori, Y., Hoppens, C. M., MacManus, L. M., Hanahan, D. J., Pinckard, R. N.: Acetyl glyceryl ether phosphorylcholine (AGEPC), a putative mediator of cardiac anaphylaxis in the guinea pig. Circ. Res. 54: 117-124, 1984.
29. Lima, M. C. R., Martins, M. A., Perez, S. A. C., Peixoto, J. M., Silva, P. M. R., Cordeiro, R. S. B.: Kinetics of pleural exudation and cellular alterations induced by antigen in actively sensitized rats. Braz. J. Med. Biol. Res. 23: 857-860, 1990.
30. Lohman, I. C. and Halonen, M.: Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on Ig E anaphylaxis in the rabbit. Am. Rev. Respir. Dis. 142: 390-397, 1990.
31. Lohman, I. C. and Halonen, M.: The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit. Am. Rev. Respir. Dis. 147: 1223-1228, 1993.
32. MacRae, W. D., Towers, G. H. N.: Biochemical activities of the lignans. Phytochemistry 24: 561-566, 1985.
33. Mesquita, L. M., Roque, N. F., Quintana, L. M. B., Paulo, M. Q., Barbosa-Filho, J. M.: Lignans from Rollinia species. Biochem. Syst. Ecol. 16: 379-380, 1988.
34. Muaecevic, G., Heuer, H. O.: Platelet-activating factor antagonists in experimental shock. Arzneim. Forsch. 42: 1001-1004, 1992.
35. Nagaoka, J., Harada, K., Kimura, A. Kobayashi, S., Murakami, M., Yoshimura, T., Yamada, K., Asano, O., Katayama, K., Yamatsu, I.: Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2- methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4-octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy] carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models. Arzneim. Forsch. 41: 719-724, 1991.
36. Osada, S., Ichiki, H., Oku, H., Ishiguro, K., Kunitomo, M., Semma, M.: Participation of nitric oxide in mouse anaphylactic hypotension. Eur. J. Pharmacol. 252: 347-350, 1994.
37. Pan, J. X., Hensens, O. D., Zink, D. L., Chang, M. N., Hwang, S. B.: Lignans with platelet-activating factor antagonist activity from Magnolia biondii. Phytochemistry 26: 1377-1379, 1987.
38. Péllon, M. I., Steil, A. A., Furió, V., Sanchez-Crespo, M.: Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis. Br. J. Pharmacol. 112: 1101-1108, 1994.
39. Peters, S. P.: Systemic anaphylaxis. In: Lichtenstein, L. M., Fauci, A. S. eds. Current Therapy in Allergy, Immunology and Rheumatology. Toronto, B. C. Decker, Inc., 75-80, 1985.
40. 4. Br. J. Pharmacol. 88: 595-605, 1986.
41. Scheffer, A. L.: Anaphylaxis. J. Allergy Clin. Immunol. 75: 227-233, 1985.
42. Smith, P. L., Kagey-Sobotka, A., Bleecker, E. R., Traystman, R., Kaplan, A. P., Gralnick, H., Valentine, M. D., Permutt, S., Lichtenstein, L. M.: Physiologic manifestations of human anaphylaxis. J. Clin. Invest. 66: 1072-1080, 1980.
43. Stewart, A. G., Dubbin, P. N., Harriś, T., Dusting, G. J.: Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from eukocytes and endothelial cells. Proc. Natl. Acad. Sci. USA 87: 3215-3219, 1990.
44. Sybertz, E. J., Watkins, R. W., Baum, T., Pula, K., Rivelli, M.: Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog. J. Pharmacol. Exp. Ther. 232: 156-162, 1985.
45. Terashita, Z. I., Imura, Y., Shino, A., Nishikawa, K.: A lethal role of platelet-activating factor in anaphylactic shock in mice. J. Pharmacol. Exp. Ther. 243: 378-383, 1987.
46. Terashita, Z. I., Tsushima, S., Yoshioka, Y., Nomura, H., Inada, Y., Nishikawa, K.: CV 3988 - a specific antagonist of platelet-activating factor (PAF). Life Sci. 32: 1975-1982, 1987.
47. Terashita, Z. I., Kawamura, M., Takatani, M., Tsushima, S., Imura, Y., Nishikawa, K.: Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in mice. J. Pharmacol. Exp. Ther. 260: 748-755, 1992.
48. Tibiriçá, E. V., Mosquera, K., Abreu, M., Ribeiro, R., Carvalho, F. A. S., Barbosa-Filho, J. M., Cordeiro, R. S. B.: Antagonistic effect of yangambin on platelet-activating factor (PAF)-induced cardiovascular collapse. Phytomedicine 2 (3): 27-34, 1995.
49. Vargaftig, B. B., Braquet, P. G.: PAF-acether today - Relevance for acute experimental anaphylaxis. Br. Med. Bull. 43: 312-335, 1987.
50. Vilain, B., Lagente, V., Touvay, C., Desquand, S., Randon, J., Lefort, J., Braquet, P., Vargaftig, B. B.: Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Pharmacol. Res. Comm. 18 (suppl.): 119-126, 1986.